Emo Capital Corp.
NUVI
$0.013
$0.00685.71%
| Weiss Ratings | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -5.76 | |||
| Price History | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 73.33% | |||
| 60-Day Total Return | -34.67% | |||
| 90-Day Total Return | 85.71% | |||
| Year to Date Total Return | -34.67% | |||
| 1-Year Total Return | 91.18% | |||
| 2-Year Total Return | -30.85% | |||
| 3-Year Total Return | 333.33% | |||
| 5-Year Total Return | 150.00% | |||
| 52-Week High % Change | -45.83% | |||
| 52-Week Low % Change | 465.22% | |||
| Price | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.02 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 26, 2024 | |||
| 52-Week High Price (Date) | Aug 29, 2024 | |||
| Valuation | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.91M | |||
| Enterprise Value | 3.93M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -100.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -65.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -2,454.81 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 300.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 628 7299 | |||
| Address | 10409 Pacific Palisades Avenue Las Vegas, NV 89144 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 99.73% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 100.00% | |||
| Balance Sheet | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | -- | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -68.80K | |||
| Current Ratio (Q) | -- | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 68.80K | |||
| Total Debt (Q) | 21.80K | |||
| Total Liabilities (Q) | 68.80K | |||
| Total Common Equity (Q) | -68.80K | |||
| Cash Flow | NUVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
